Back to Search Start Over

Facial redness in Japanese adolescents with atopic dermatitis treated with dupilumab: A case series

Authors :
Shuhei Hara, MD
Takaaki Itonaga, MD
Makoto Nishino, MD
Noriyuki Yanagida, MD, PhD
Sakura Sato, MD
Motohiro Ebisawa, MD, PhD
Source :
Journal of Allergy and Clinical Immunology: Global, Vol 2, Iss 2, Pp 100096- (2023)
Publication Year :
2023
Publisher :
Elsevier, 2023.

Abstract

This case series study is the first report of Japanese adolescents who experienced dupilumab facial redness after starting dupilumab treatment for refractory atopic dermatitis. In every case, dupilumab facial redness subsided without discontinuation of dupilumab within 3 months after onset.

Details

Language :
English
ISSN :
27728293
Volume :
2
Issue :
2
Database :
Directory of Open Access Journals
Journal :
Journal of Allergy and Clinical Immunology: Global
Publication Type :
Academic Journal
Accession number :
edsdoj.6b89bc01ccae48a389d496feacd08047
Document Type :
article
Full Text :
https://doi.org/10.1016/j.jacig.2023.100096